CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +4,000 | $22.30 | $89K | 17,276 |
| 2021-01-04 | Verstraete Stephany Chief Marketing Officer | Sale | −4,000 | $199.80 | $799K | 13,276 |
| 2021-01-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Employee Stock Option (right to buy) | −4,000 | 22,600 | ||
| 2021-01-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +1,447 | $22.30 | $32K | 1,647 |
| 2021-01-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +1,082 | $38.55 | $42K | 2,729 |
| 2021-01-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −2,529 | $199.80 | $505K | 200 |
| 2021-01-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Employee Stock Option (right to buy) | −1,447 | 2,893 | ||
| 2021-01-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Employee Stock Option (right to buy) | −1,082 | 16,387 | ||
| 2020-12-15 | WANG YULUN Head of Research & Development | Option exercise | +4,500 | $16.92 | $76K | 4,500 |
| 2020-12-15 | WANG YULUN Head of Research & Development | Option exercise · Employee Stock Option (right to buy) | −4,500 | 52,865 | ||
| 2020-12-14 | WANG YULUN Head of Research & Development | Option exercise | +2,500 | $16.92 | $42K | 2,500 |
| 2020-12-14 | WANG YULUN Head of Research & Development | Sale | −2,500 | $199.24 | $498K | 0 |
| 2020-12-14 | WANG YULUN Head of Research & Development | Option exercise · Employee Stock Option (right to buy) | −2,500 | 57,365 | ||
| 2020-12-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +3,000 | $22.30 | $67K | 11,413 |
| 2020-12-10 | Trencher Daniel SVP Corporate Strategy | Sale | −3,000 | $192.17 | $577K | 8,413 |
| 2020-12-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −3,000 | 49,414 | ||
| 2020-12-08 | Taneja Hemant Director | Sale | −4,900 | $197.39 | $967K | 0 |
| 2020-12-04 | WANG YULUN Head of Research & Development | Option exercise | +1,069 | $16.92 | $18K | 1,069 |
| 2020-12-04 | WANG YULUN Head of Research & Development | Sale | −1,069 | $198.00 | $212K | 0 |
| 2020-12-04 | WANG YULUN Head of Research & Development | Option exercise | +5,000 | $16.92 | $85K | 5,000 |
Page 84 of 93 · 1,848 trades